NAT for HBV and anti-HBc testing increase blood safety

Transfusion

Volumn 42, Issue 7, 2002, Pages 869-875

  Roth, W Kurt ^a,b   Weber, Marijke ^a,b   Petersen, Detlev ^a,b   Drosten, Christian ^a,b   Buhr, Sylvia ^a,b   Sireis, Walid ^a,b   Weichert, Wolfgang ^a,b   Hedges, Doris ^a,b   Seifried, Erhard ^a,b  

^a Institute of Transfusion Medicine and Immunohematology   (Germany)

^b Institute Wiesentheid of the Bavarian Red Cross   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; VIRUS ANTIBODY; VIRUS DNA;

ARTICLE; BLOOD; BLOOD BANK; BLOOD DONOR; BLOOD TRANSFUSION; DISEASE TRANSMISSION; GENETICS; GERMANY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOLOGY; MASS SCREENING; METHODOLOGY; NUCLEIC ACID AMPLIFICATION; SAFETY; SENSITIVITY AND SPECIFICITY; STANDARD; VIROLOGY;

ANTIBODIES, VIRAL; BLOOD; BLOOD BANKS; BLOOD DONORS; BLOOD TRANSFUSION; CONSUMER PRODUCT SAFETY; DNA, VIRAL; GERMANY; HEPATITIS B; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; MASS SCREENING; NUCLEIC ACID AMPLIFICATION TECHNIQUES; SENSITIVITY AND SPECIFICITY;

EID: 0036654287     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2002.00128.x     Document Type: Article

References (34)

1. 1 Schreiber GB, Busch MP, Kleinman SH, Koreliz JJ. The risk of transfusion‐transmitted viral infections. The Retrovirus Epidemiology Donor Study. New Engl J Med 1996 ; 334: 1685 ‐ 90.
2. 2 Glück D, Maurer C, Kubanek B. HIV, HCV and HBV in blood donors. The study group Berufsverband Deutscher Transfusionsmediziner e. V. Infusionsther Transfusionsmed 1997;24:167‐70.
3. 3 Roth WK, Weber M, Seifried E. Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV‐1 in a blood‐bank setting. Lancet 1999 ; 353: 359 ‐ 63.
4. 4 Thiers V, Nakajima E, Kremsdorf D, et al. Transmission of hepatitis B from hepatitis‐B‐seronegative subjects. Lancet 1988 ; 2: 1273 ‐ 6.
5. 5 Paterlini P, Gerken G, Nakajima E, et al. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N Engl J Med 1990;323:80‐5.
6. 6 Marcellin P, Martinot‐Peignoux M, Loriot MA, et al. Persistence of hepatitis B virus DNA demonstrated by polymerase chain reaction in serum and liver after loss of HBsAg induced by antiviral therapy. Ann Intern Med 1990 ; 112: 227 ‐ 8.
7. 7 Liang TJ, Blum HE, Wands JR. Characterization and biological properties of a hepatitis B virus isolated from a patient without hepatitis B virus serologic markers. Hepatology 1990 ; 12: 204 ‐ 12.
8. 8 Shih LN, Sheu JC, Wang JT, et al. Serum hepatitis B virus DNA in healthy HBsAg‐negative Chinese adults evaluated by polymerase chain reaction. J Med Virol 1990 ; 32: 257 ‐ 60.
9. 9 Luo KX, Zhou R, He C, et al. Hepatitis B virus DNA in sera of virus carriers positive exclusively for antibodies to the hepatitis B core antigen. J Med Virol 1991 ; 35: 55 ‐ 9.
10. 10 Pao CC, Yao DS, Lin CY, et al. Serum hepatitis B virus DNA in hepatitis B virus seropositive and seronegative patients with normal liver function. Am J Clin Pathol 1991 ; 95: 591 ‐ 6.
11. 11 Wang JT, Wang TH, Sheu JC, et al. Detection of hepatitis B virus DNA by polymerase chain reaction in plasma of volunteer blood donors negative for hepatitis B surface antigen. J Infect Dis 1991 ; 163: 397 ‐ 9.
12. 12 Adachi H, Kaneko S, Matsushita E, et al. Clearance of HBsAg in seven patients with chronic hepatitis B. Hepatology 1992 ; 16: 1334 ‐ 7.
13. 13 Paterlini P, Driss F, Nalpas B, et al. Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg‐negative patients: a study of low‐endemic area. Hepatology 1993 ; 17: 20 ‐ 9.
14. 14 Liang TJ, Bodenheimer HC Jr, Yankee R, et al. Presence of hepatitis B and C viral genomes in US blood donors as detected by polymerase chain reaction amplification. J Med Virol 1994 ; 42: 151 ‐ 7.
15. 15 Mosley JW, Stevens CE, Aach RD, et al. Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients. Transfusion 1995 ; 35: 5 ‐ 12.
16. 16 Paterlini P, Poussin K, Kew M, et al. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepatology 1995 ; 21: 313 ‐ 21.
17. 17 Rasenack JW, Schlayer HJ, Hettler F, et al. Hepatitis B virus infection without immunological markers after open‐heart surgery. Lancet 1995 ; 345: 355 ‐ 7.
18. 18 Saraswat S, Banerjee K, Chaudhury N, et al. Post‐transfusion hepatitis type B following multiple transfusions of HBsAg‐negative blood. J Hepatol 1996 ; 25: 639 ‐ 43. DOI: 10.1016/s0168-8278(96)80232-7
19. 19 Hennig H, Dennin RH, Haase D, Kirchner H. HBV‐DNA positive findings in HBsAg negative blood donors and patients. Beitr Infusionsther Transfusionsmed 1997 ; 34: 26 ‐ 30.
20. 20 Bahn A, Gerner P, Martine U, et al. Detection of different viral strains of hepatitis B virus in chronically infected children after seroconversion from HBsAg to anti‐HBs indicating viral persistence. J Hepatol 1997 ; 27: 973 ‐ 8.
21. 21 Attallah AM, Hussein M, Tabll A, et al. High prevalence of hepatitis B viral DNA in cirrhotic patients without surface antigen. Trans R Soc Trop Med Hyg 1998 ; 92: 516 ‐ 7.
22. 22 Jongerius JM, Wester M, Cuypers HTM, et al. New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays. Transfusion 1998 ; 38: 56 ‐ 9.
23. 23 Infectious disease testing for blood transfusions. NIH Consensus Statement 1995;13:1‐27.
24. 24 Peddada L, Heldebrant C, Smith R, et al. HBV viremia preceding HBsAg positivity: implications for minipool (MP) and individual donation (ID) HBV nucleic acid testing (NAT). Transfusion 2000 ; 40 (Suppl): S49 ‐ 301.
25. 25 Tabor E, Yu MY, Hewlett I, Epstein JS. Summary of a workshop on the implementation of NAT to screen donors of blood and plasma for viruses. Transfusion 2000 ; 40: 1273 ‐ 5. DOI: 10.1046/j.1537-2995.2000.40101273.x
26. 26 Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996 ; 6: 986 ‐ 94.
27. 27 Drosten C, Weber M, Seifried E, Roth WK. Evaluation of a new PCR assay with competitive internal control sequence for blood donor screening. Transfusion 2000 ; 40: 718 ‐ 24. DOI: 10.1046/j.1537-2995.2000.40060718.x
28. 28 Galibert F, Mandart E, Fitoussi F, et al. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature 1979 ; 281: 646 ‐ 50.
29. 29 Van de Peer Y, De Wachter R. Treecon for Windows: a software package for the construction and drawing of evolutionary trees for the Microsoft Windows environment. Comput Applic Biosci 1994 ; 10: 569 ‐ 70.
30. 30 Kimura M. A simple method for estimating evolutionary rate of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 1980 ; 16: 111 ‐ 20.
31. 31 Saitou N, Nei M. The neighbor‐joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987 ; 4: 406 ‐ 25.
32. 32 Felsenstein J. Confidence limits on phylogenies: an approach using the bootstrap. Evolution 1985 ; 39: 783 ‐ 91.
33. 33 Grob P, Jilg W, Bornhak H, et al. Serological pattern ‘anti‐HBc alone.’ Report on a workshop. J Med Virol 2000 ; 62: 450 ‐ 5.
34. 34 Fields BN, Knipe DM, Howley PM, editors. Fields virology. 3rd ed. Philadelphia/New York: Lippincott‐Raven; 1996.